Adaptilens
Adaptilens, Inc. is developing a biomimetic intraocular lens (A-IOL) designed to restore youthful vision after cataract surgery. Their A-IOL imitates the human lens's ability to focus at various distances, eliminating the need for glasses or contacts. This aims to revolutionize cataract surgery and improve the quality of life for millions.
Funding Round: Series A
Funding Amount: $17.5M
Date: 29-Apr-2024
Investors: Perceptive Xontogeny Venture Funds (PXV Funds), Pillar VC, 380 Cap, Accanto Partners
Markets: Medtech, Biotechnology, Ophthalmology
HQ: Boston, Massachusetts, United States
Founded: 2019
Website: https://adaptilens.com/
LinkedIn: https://www.linkedin.com/company/adaptilens
Crunchbase: https://www.crunchbase.com/organization/adaptilens
Leave a Comment
Comments
No comments yet.